started doing people that were younger than 16. you remember their vaccine is for 16 and older. but as you mention, let me show you, this is some of the youngest trial participants that we ve now heard. over 6,000 people age 6 months to 11 years. and then you have 3,000 adolescents, age 12 to 17 years. what s happening now is they re going to trial these, again, very young participants with various doses of the vaccine. 25 micro gram, 50 microgram, 100 mi microgram. they re trying to figure out two things, is this safe in people of that age and what is the right dose to give as well. after that, if those things sort of if they get the information they need and sprois proven safe, they can bridge these trials to existing trials. meaning, hey, we get a lot of information. they could get some results early. as you heard, dr. fauci said by the fall potentially high school students potentially could have a vaccine. i was going to ask you about the timeline there. so if this go
determine whether its coronavirus vaccine is safe for infants and young children. this is so important. it s important for school. it s important for getting and keeping the country back to normal. the first participants have already been vaccinated. the plan is to ultimately enroll nearly 7,000 children in the u.s. and canada between the ages of 6 months and 11 years old. also the white house drawing up plans to increase the supply of vaccines to emerging hot spots. the vaccination rate in the u.s. is accelerating. now standing at an average 26.4 million shots reported a day. president biden meantime heading to pennsylvania. a bit later. his first stop on the help is here tour where he ll promote the benefits of the coronavirus b relief bill. let s bring in dr. sanjay gupta. obviously, very important because when we talk about getting everyone, all adult americans vaccinated by may 1st or july 1st, we re not even beginning to talk about kids yet. that s why this trial ma